Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2018 | -2 Million USD | 59.34% |
| 2017 | -4.93 Million USD | 4.84% |
| 2016 | -5.18 Million USD | -60.87% |
| 2015 | -3.22 Million USD | -1.2% |
| 2014 | -3.18 Million USD | -17.13% |
| 2013 | -2.71 Million USD | -3.94% |
| 2012 | -2.61 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2019 Q2 | -372.54 USD | 3.16% |
| 2019 Q3 | -355.79 USD | 4.5% |
| 2019 Q1 | -384.69 USD | 29.52% |
| 2018 Q4 | -545.80 USD | -101.6% |
| 2018 FY | -2 Million USD | 59.34% |
| 2018 Q1 | -704.63 USD | 42.77% |
| 2018 Q2 | -416.87 USD | 40.84% |
| 2018 Q3 | -270.74 USD | 35.05% |
| 2017 Q3 | -1142.97 USD | 16.86% |
| 2017 Q2 | -1374.75 USD | -13.06% |
| 2017 Q1 | -1215.94 USD | 10.28% |
| 2017 FY | -4.93 Million USD | 4.84% |
| 2017 Q4 | -1231.32 USD | -7.73% |
| 2016 Q4 | -1355.26 USD | 13.45% |
| 2016 Q3 | -1565.90 USD | -21.05% |
| 2016 FY | -5.18 Million USD | -60.87% |
| 2016 Q2 | -1293.60 USD | -26.67% |
| 2016 Q1 | -1021.27 USD | -18.14% |
| 2015 FY | -3.22 Million USD | -1.2% |
| 2015 Q4 | -864.45 USD | -26.24% |
| 2015 Q3 | -684.79 USD | 7.61% |
| 2015 Q2 | -741.21 USD | -6.84% |
| 2015 Q1 | -693.76 USD | 15.54% |
| 2014 FY | -3.18 Million USD | -17.13% |
| 2014 Q3 | -775.24 USD | 5.37% |
| 2014 Q2 | -819.25 USD | 6.28% |
| 2014 Q1 | -874.12 USD | 20.5% |
| 2014 Q4 | -821.42 USD | -5.96% |
| 2013 Q4 | -1099.56 USD | -81.26% |
| 2013 FY | -2.71 Million USD | -3.94% |
| 2013 Q2 | -574.26 USD | -18.39% |
| 2013 Q1 | -485.06 USD | -6.23% |
| 2013 Q3 | -606.63 USD | -5.64% |
| 2012 FY | -2.61 Million USD | 0.0% |
| 2012 Q4 | -456.61 USD | 32.84% |
| 2012 Q2 | -763.56 USD | 0.0% |
| 2012 Q3 | -679.84 USD | 10.96% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HST Global, Inc. | -140.9 Thousand USD | -1322.752% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -191.834% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -1068.889% |
| CytoDyn Inc. | -18.05 Million USD | 88.898% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 96.602% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| MultiCell Technologies, Inc. | -722.81 USD | -277256.013% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -10.375% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 60.258% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -6593.233% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -1004.641% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Cognition Inc. | -9.7 Million USD | 79.344% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 96.388% |
| SQZ Biotechnologies Company | -75.82 Million USD | 97.356% |
| Resverlogix Corp. | -12.74 Million USD | 84.275% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -414.608% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 120.578% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 18.35% |
| Mesoblast Limited | -84.14 Million USD | 97.618% |
| GB Sciences, Inc. | -1.42 Million USD | -41.129% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -191.834% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 88.767% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 41.123% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 69.844% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 36.724% |
| ContraFect Corporation | -56.88 Million USD | 96.476% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 27.122% |
| BioStem Technologies, Inc. | -7.77 Million USD | 74.228% |
| LadRx Corporation | -3.82 Million USD | 47.569% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 87.367% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -79.156% |
| CSL Limited | 3.7 Billion USD | 100.054% |
| Biomind Labs Inc. | -1 Million USD | -98.569% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -115.246% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 102.449% |
| Nascent Biotech, Inc. | -2.22 Million USD | 10.096% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 97.207% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 140.79% |
| GeneThera, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 156.632% |
| Adynxx, Inc. | - USD | Infinity% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -30.514% |
| Marizyme, Inc. | -34.08 Million USD | 94.119% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 75.991% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -254.998% |
| Zenith Capital Corp. | -8.94 Million USD | 77.583% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 29.67% |
| Halberd Corporation | -75.05 Thousand USD | -2571.229% |
| Genus plc | 6.4 Million USD | 131.324% |
| Pharming Group N.V. | -4.87 Million USD | 58.915% |
| MetaStat, Inc. | - USD | Infinity% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -0.92% |
| IMV Inc. | -38.67 Million USD | 94.816% |
| Affymax, Inc. | -15.04 Million USD | 86.676% |
| SYBLEU INC | -149.18 Thousand USD | -1243.851% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -92.027% |
| Enzolytics Inc. | -2.14 Million USD | 6.703% |
| argenx SE | -425.04 Million USD | 99.528% |
| AVAX Technologies, Inc. | 6.69 Million USD | 129.954% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -42.994% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -50.121% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | 46.489% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -7864.867% |
| Cell Source, Inc. | -4.32 Million USD | 53.651% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -315.01% |
| Q BioMed Inc. | -3.44 Million USD | 41.817% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 52.7% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -59.614% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 23.702% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 55.985% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 96.353% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 30.9% |
| Rebus Holdings, Inc. | -664 Thousand USD | -201.921% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -103.724% |
| Skye Bioscience, Inc. | -13.67 Million USD | 85.337% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -7.53% |
| ONE Bio Corp. | 13.68 Million USD | 114.653% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -3.733% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -78.216% |
| Agentix Corp. | -1.37 Million USD | -46.145% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 31.331% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -26.935% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -11407.703% |
| Kadimastem Ltd | -3.04 Million USD | 34.059% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -665.975% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -382.517% |
| NovAccess Global Inc. | -2.46 Million USD | 18.729% |
| Itoco Inc. | -919.14 Thousand USD | -118.112% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -810.93% |
| Qrons Inc. | -643.67 Thousand USD | -211.454% |
| Mobile Lads Corp. | -554.55 Thousand USD | -261.511% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.518% |
| International Stem Cell Corporation | -663 Thousand USD | -202.377% |
| Bioxytran, Inc. | -3.82 Million USD | 47.521% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3708.429% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -9756.229% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 94.472% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -23.903% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -172.447% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 35.559% |
| Neutra Corp. | -229.48 Thousand USD | -773.586% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 88.57% |
| PureTech Health plc | -146.19 Million USD | 98.629% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 90.672% |
| IXICO plc | -1.43 Million USD | -39.51% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 78.877% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 98.354% |
| CSL Limited | 3.81 Billion USD | 100.053% |
| Cellectis S.A. | -108.85 Million USD | 98.158% |